| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |